Phase II trial of dacomitinib, a pan–human EGFR tyrosine kinase inhibitor, in recurrent glioblastoma patients with EGFR amplification-Reference-Cited by-同舟云学术

Phase II trial of dacomitinib, a pan–human EGFR tyrosine kinase inhibitor, in recurrent glioblastoma patients with EGFR amplification

Published:2017-06-01 Issue:11 Volume:19 Page:1522-1531
ISSN:1522-8517
Container-title:Neuro-Oncology
language:en
Short-container-title:

Author:

Sepúlveda-Sánchez Juan Manuel,Vaz María Ángeles,Balañá Carmen,Gil-Gil Miguel,Reynés Gaspar,Gallego Óscar,Martínez-García María,Vicente Elena,Quindós María,Luque Raquel,Ramos Ana,Ruano Yolanda,Pérez-Segura Pedro,Benavides Manuel,Sánchez-Gómez Pilar,Hernández-Laín Aurelio

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Neurology (clinical),Oncology

Link

http://academic.oup.com/neuro-oncology/article-pdf/19/11/1522/22934258/nox105.pdf

Reference34 articles.

1. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma;European Organisation for Research and Treatment of Cancer Brain Tumor and Radiotherapy Groups; National Cancer Institute of Canada Clinical Trials Group;N Engl J Med,2005

2. Molecular determinants of the response of glioblastomas to EGFR kinase inhibitors;N Engl J Med,2005

3. EGFR wild-type amplification and activation promote invasion and development of glioblastoma independent of angiogenesis;Acta Neuropathol,2013

4. Mutant epidermal growth factor receptor up-regulates molecular effectors of tumor invasion;Cancer Res,2002

5. Efficacy of erlotinib in patients with relapsed gliobastoma multiforme who expressed EGFRVIII and PTEN determined by immunohistochemistry;J Neurooncol,2014

Cited by 91 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Phase II Trial of Afatinib in Patients With EGFR-Mutated Solid Tumors Excluding Lung Cancer: Results From NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol A;JCO Precision Oncology;2024-07

2. Selective regulation of chemosensitivity in glioblastoma by phosphatidylinositol 3-kinase beta;iScience;2024-06

3. Revolutionizing Glioblastoma Treatment: A Comprehensive Overview of Modern Therapeutic Approaches;International Journal of Molecular Sciences;2024-05-26

4. Mechanistic insights and the clinical prospects of targeted therapies for glioblastoma: a comprehensive review;Experimental Hematology & Oncology;2024-04-13

5. Comprehensive mutational scanning of EGFR reveals TKI sensitivities of extracellular domain mutants;Nature Communications;2024-03-28